ABSTRACT
Background Degenerative rotator cuff tears (DCTs) are the leading cause of shoulder pain, affecting 30% to 50% of individuals over 50. Current phenotyping strategies for DCT rely on heterogeneous combinations of procedural and diagnostic codes, leading to concerns about misclassification. We aimed to create universal phenotypic algorithms to classify DCT status across EHR systems.
Methods Using Vanderbilt University Medical Center’s de-identified EHR system, we developed and validated two sets of algorithms—one requiring imaging verification and one without imaging verification—to identify DCT cases and controls. The algorithms used combinations of ICD and CPT codes, as well as natural language processing (NLP), to increase diagnostic certainty. Manual chart reviews by trained personnel blinded to case-control determinations were conducted to compute positive (PPV) and negative predictive values (NPV).
Results The algorithm development process resulted in five phenotypes with an overall predictive value of 94.5%. By approach: 1) code only cases that required imaging confirmation (PPV = 89%), 2) code only cases that did not require imaging verification (PPV = 92%), 3) NLP-based cases that did not require imaging verification (PPV = 89%), 4) code-based controls that were confirmed by imaging (NPV = 90%), and 5) code and NLP-based controls that did not require imaging verification (NPV = 100%). External validation demonstrated 94% sensitivity and 75% specificity for the code-only algorithms. The addition of NLP increased the number of identified cases without compromising predictive values.
Conclusions These algorithms represent an improvement over current phenotyping strategies and allows for EHR studies of unprecedented size
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the NIH grant numbers: 1R01AR074989 (NIAMS), 5F31AR082662-02 (NIAMS), and T32GM007347 (NIGMS)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the VUMC IRB (#140857 and #060109) and the UTSW IRB (#STU-2020-0572 and #STU-2020-0978)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
